#1 Clinical Trials Search in Europe

Sodium Hydrogen Carbonate Pheur

This article explores recent clinical trials investigating the use of sodium hydrogen carbonate (also known as sodium bicarbonate) in treating various medical conditions. These trials cover a range of applications, from respiratory diseases to cancer treatments, highlighting the versatility and potential of this compound in medical research.

Table of Contents

What is SODIUM HYDROGEN CARBONATE PHEUR?

SODIUM HYDROGEN CARBONATE PHEUR, also known as sodium bicarbonate, is a chemical compound with the formula NaHCO3[1]. It is a white, crystalline powder that is commonly used in medical settings for various purposes. This substance is an essential component in many pharmaceutical formulations and medical treatments.

Medical Uses

SODIUM HYDROGEN CARBONATE PHEUR has several important medical applications:

  • Electrolyte Balance: It is often used as part of electrolyte solutions to help maintain proper fluid and electrolyte balance in the body[2].
  • pH Regulation: As a buffer, it can help regulate pH levels in the blood and other bodily fluids[2].
  • Respiratory Support: In some cases, it may be used to help improve breathing in patients with certain respiratory conditions[3].
  • Cardiac Support: It can be used in emergency situations to help treat severe acidosis, which can occur in some cardiac conditions[4].

How is it Administered?

SODIUM HYDROGEN CARBONATE PHEUR can be administered in various ways, depending on the specific medical condition and treatment plan. Some common methods include:

  • Intravenous (IV) Infusion: Often used in hospital settings for rapid correction of electrolyte imbalances or severe acidosis[2].
  • Oral Solution: May be given by mouth for certain conditions, though this is less common in acute medical settings.
  • Inhalation: In some respiratory conditions, it may be administered as an inhaled solution[3].

Current Clinical Trials

SODIUM HYDROGEN CARBONATE PHEUR is being studied in various clinical trials for different medical conditions:

  • Interstitial Lung Disease (ILD): It is being used as part of an electrolyte solution in a study investigating a new treatment for ILD[2].
  • Propionic Acidemia: Researchers are using it as part of an electrolyte solution in a study on a potential new therapy for this rare genetic disorder[5].
  • Bronchiectasis: A clinical trial is exploring the benefits of inhaling a hypertonic saline solution (which may include sodium bicarbonate) prior to physiotherapy in patients with bronchiectasis[3].

Potential Side Effects

While SODIUM HYDROGEN CARBONATE PHEUR is generally considered safe when used as directed, it can potentially cause side effects, especially if used in high doses or for prolonged periods. Some possible side effects include:

  • Nausea and vomiting
  • Stomach pain
  • Headache
  • Electrolyte imbalances
  • In rare cases, alkalosis (when the body becomes too alkaline)

It’s important to note that these side effects are more commonly associated with excessive use or misuse of the substance. When administered by healthcare professionals in controlled settings, the risk of side effects is generally low[6].

Precautions and Contraindications

While SODIUM HYDROGEN CARBONATE PHEUR is widely used in medical settings, there are some situations where caution is needed:

  • Kidney Problems: Patients with kidney issues may need dose adjustments or close monitoring when receiving this medication.
  • Heart Conditions: In some cardiac conditions, the use of sodium bicarbonate needs to be carefully controlled.
  • Electrolyte Imbalances: Patients with existing electrolyte disorders may require special consideration.
  • Pregnancy and Breastfeeding: While generally considered safe, use during pregnancy or while breastfeeding should be discussed with a healthcare provider.

Always inform your healthcare provider about all medications you are taking and any existing health conditions before starting any new treatment involving SODIUM HYDROGEN CARBONATE PHEUR[7].

Trial Focus Condition Use of Sodium Hydrogen Carbonate Key Outcomes Measured
Rituximab in ILD Interstitial Lung Disease Component in intravenous solution Change in Forced Vital Capacity (FVC), progression-free survival
mRNA-3927 in Propionic Acidemia Propionic Acidemia Component in intravenous solution Safety, tolerability, pharmacodynamics, pharmacokinetics
mRNA-3745 in GSD1a Glycogen Storage Disease Type 1a Component in intravenous solution Safety, tolerability, pharmacodynamics, pharmacokinetics
CAEL-101 in AL Amyloidosis AL Amyloidosis Component in intravenous solution Overall survival, cardiovascular hospitalizations
Hypertonic Saline in Bronchiectasis Bronchiectasis 7% hypertonic saline for inhalation Mucus clearance, quality of life, pulmonary function
SBP-101 in Pancreatic Cancer Metastatic Pancreatic Ductal Adenocarcinoma Component in placebo formulation Overall survival, progression-free survival

FAQ

  • What is sodium hydrogen carbonate and how is it used in medicine? Sodium hydrogen carbonate, also known as sodium bicarbonate, is a chemical compound with the formula NaHCO3. In medicine, it's used in various ways, including as an antacid, in intravenous fluids, and in some respiratory treatments. The clinical trials discussed here explore its potential in treating conditions like interstitial lung disease, propionic acidemia, and as a component in treatments for pancreatic cancer and AL amyloidosis.
  • What types of medical conditions are being studied using sodium hydrogen carbonate? The clinical trials mentioned in this article investigate the use of sodium hydrogen carbonate in several medical conditions, including interstitial lung disease (ILD), propionic acidemia, glycogen storage disease type 1a (GSD1a), AL amyloidosis, bronchiectasis, and metastatic pancreatic ductal adenocarcinoma.
  • How is sodium hydrogen carbonate administered in these trials? The administration of sodium hydrogen carbonate varies depending on the trial and condition being treated. It's used in intravenous solutions, inhalation treatments, and as a component in other drug formulations. For example, in the bronchiectasis trial, it's used as a 7% hypertonic saline solution for inhalation.
  • Are there any side effects or risks associated with using sodium hydrogen carbonate? While specific side effects aren't detailed in these trial summaries, many of the studies include safety assessments as part of their objectives. It's important to note that any medical treatment can have potential side effects, and these are carefully monitored in clinical trials. Patients should always discuss potential risks and benefits with their healthcare providers.
  • What are the potential benefits of using sodium hydrogen carbonate in these treatments? The potential benefits vary depending on the condition being treated. For example, in bronchiectasis, the inhalation of hypertonic saline containing sodium hydrogen carbonate may help with mucus clearance. In other trials, it's used as part of combination therapies or as a component in drug formulations. The trials aim to assess improvements in various outcomes such as lung function, quality of life, and overall survival in different conditions.

Ongoing Clinical Trials on Sodium Hydrogen Carbonate Pheur

  • A study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark France Germany Italy The Netherlands +1

  • A Study Testing Erector Spinae Plane Block with Ropivacaine versus Placebo for Pain Relief in Adults with Acute Kidney Stone Pain in the Emergency Department

    Recruiting

    3 1 1
    Investigated drugs:
    The Netherlands

  • Study on Rituximab for Patients with Rheumatoid Arthritis: Comparing 200 mg and 1g Doses for Maintenance Treatment

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Efficacy of Sivelestat in Patients with Septic Coagulopathy: A Phase IIb Randomized Controlled Trial

    Not yet recruiting

    2 1 1
    Investigated drugs:
    France

  • Long-term safety study of NNC6019-0001 for patients with transthyretin amyloid cardiomyopathy (ATTR-CM)

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia France Germany Italy The Netherlands Portugal +1

  • Study of SBP-101, Nab-Paclitaxel, and Gemcitabine for Patients with Metastatic Pancreatic Cancer

    Not recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium France Germany Italy Spain

  • Study on the Safety and Effectiveness of mRNA-3927 for Patients with Propionic Acidemia

    Not recruiting

    2 1 1 1
    Investigated drugs:
    France Italy The Netherlands Spain

  • Study on the Effectiveness and Safety of CAEL-101 with Plasma Cell Dyscrasia Treatment in Patients with Stage IIIa AL Amyloidosis

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Czechia France Germany Greece Italy +2

Glossary

  • Sodium Hydrogen Carbonate: Also known as sodium bicarbonate or baking soda, it's a chemical compound with the formula NaHCO3. In medicine, it's used for various purposes including as an antacid and in some intravenous fluids.
  • Interstitial Lung Disease (ILD): A group of disorders that cause inflammation and scarring of the lung tissue, affecting the ability to breathe and get enough oxygen into the bloodstream.
  • Propionic Acidemia: A rare inherited disorder in which the body is unable to process certain parts of proteins and fats properly due to a deficiency of a specific enzyme.
  • Glycogen Storage Disease Type 1a (GSD1a): A genetic disorder that affects the body's ability to break down stored glucose, leading to problems with blood sugar regulation and other metabolic issues.
  • AL Amyloidosis: A rare disease where abnormal proteins build up in organs and tissues, affecting their function. 'AL' stands for 'amyloid light chain'.
  • Bronchiectasis: A chronic condition where the airways of the lungs become abnormally widened, leading to a build-up of excess mucus that makes the lungs more vulnerable to infection.
  • Metastatic Pancreatic Ductal Adenocarcinoma: An advanced form of pancreatic cancer that has spread from the pancreas to other parts of the body.
  • Hypertonic Saline: A solution with a higher concentration of salt (sodium chloride) than is found in body cells. In these trials, it includes sodium hydrogen carbonate.
  • ELTGOL: A chest physiotherapy technique (Expiration with the Glottis Open in the Lateral Posture) used to help clear mucus from the lungs.
  • Forced Vital Capacity (FVC): The total amount of air exhaled during a forced breath, a measure of lung function.

References

  1. https://pubchem.ncbi.nlm.nih.gov/compound/Sodium-bicarbonate
  2. http://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-rituximab-for-patients-with-progressive-interstitial-lung-disease-with-inflammation/
  3. http://clinicaltrials.eu/trial/study-on-the-effects-of-7-hypertonic-saline-inhalation-and-eltgol-physiotherapy-for-patients-with-bronchiectasis/
  4. http://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-cael-101-with-plasma-cell-dyscrasia-treatment-in-patients-with-stage-iiia-al-amyloidosis/
  5. http://clinicaltrials.eu/trial/study-on-the-safety-and-effectiveness-of-mrna-3927-for-patients-with-propionic-acidemia/
  6. https://www.ncbi.nlm.nih.gov/books/NBK482340/
  7. https://www.drugs.com/mtm/sodium-bicarbonate.html